CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
AbbVie Inc. (ABBV) is a research-based pharmaceutical company specialising in the discovery and development of biopharmaceuticals, and small molecule drugs. With a team of 28,000 scientists and researchers across the globe, the company introduces new approaches to treating chronic conditions and life-threatening health issues. AbbVie produces medicines aimed at treating autoimmune diseases; oncology; virology, including hepatitis C and HIV; neurological; and metabolic disorders. The company focuses on developing and delivering innovative solutions for treating the most dangerous and challenging diseases known worldwide. Browse the AbbVie share price (ABBV) chart in real-time and seize an investment opportunity with a world-leading pharmaceutical company at Capital.com.
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.